Adjuvant activity of chicken interleukin-12 co-administered with infectious bursal disease virus recombinant VP2 antigen in chickens

Veterinary Immunology and Immunopathology

Volumn 139, Issue 2-4, 2011, Pages 167-175

  Su, Bor Sheu ^a   Chiu, Hua Hsien ^b   Lin, Cheng Chung ^a   Shien, Jui Hung ^a   Yin, Hsien Sheng ^c   Lee, Long Huw ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b FOOYIN UNIVERSITY   (Taiwan)

^c NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Bursal protection; Chicken IL 12; Eukaryotic expression; IBDV VP2; Recombinant FPV

Indexed keywords

GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; NEUTRALIZING ANTIBODY; PROTEIN VP2; RECOMBINANT INTERLEUKIN 12;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; CELL CULTURE; CHICKEN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; DRUG SYNTHESIS; FOWLPOX VIRUS; GENE AMPLIFICATION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNE RESPONSE; IN VIVO STUDY; INFECTIOUS BURSAL DISEASE; INFECTIOUS BURSAL DISEASE VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTECTION; PROTEIN ANALYSIS; PROTEIN PURIFICATION; SPLEEN CELL; SUPERNATANT; TREATMENT DURATION; VIRUS NEUTRALIZATION; VIRUS STRAIN;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIRNAVIRIDAE INFECTIONS; CHICKENS; FOWLPOX VIRUS; INFECTIOUS BURSAL DISEASE VIRUS; INTERLEUKIN-12; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EUKARYOTA; FOWLPOX VIRUS; GALLUS GALLUS; INFECTIOUS BURSAL DISEASE VIRUS;

EID: 78650875603     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.10.001     Document Type: Article

References (25)

1. Arulanandam B.P., Van Cleave V.H., Metzger D.W. IL-12 is a potent neonatal vaccine adjuvant. Eur. J. Immunol. 1999, 29:256-264.
2. Chakrabarti S., Sisler J.R., Moss B. Compact, synthetic, vaccinia virus early/late promoter for protein expression. Biotechniques 1997, 23:1094-1097.
3. Degen W.G., van Daal N., van Zuilekom H.I., Burnside J., Schijns V.E. Identification and molecular cloning of functional chicken IL-12. J. Immunol. 2004, 172:4371-4380.
4. Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response. J. Immunol. 1999, 162:4511-4520.
5. Heath A.W. Cytokines as immunological adjuvants. Pharmacol. Biotechnol. 1995, 6:645-658.
6. Hilton L.S., Bean A.G., Lowenthal J.W. The emerging role of avian cytokines as immunotherapeutics and vaccine adjuvants. Vet. Immunol. Immunopathol. 2002, 85:119-128.
7. Jacobson M.A., Sinclair E., Bredt B., Agrillo L., Black D., Epling C.L., Carvidi A., Ho T., Bains R., Girling V., Adler S.P. Safety and immunogenicity of Towne cytomegalovirus vaccine with or without adjuvant recombinant interleukin-12. Vaccine 2006, 24:5311-5319.
8. Kobayashi M., Fitz L., Ryan M., Hewick R.M., Clark S.C., Chan S., Loudon R., Sherman F., Perussia B., Trinchieri G. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 1989, 170:827-845.
9. Laidlaw S.M., Anwar M.A., Thomas W., Green P., Shaw K., Skinner M.A. Fowlpox virus encodes nonessential homologs of cellular alpha-SNAP, PC-1, and an orphan human homolog of a secreted nematode protein. J. Virol. 1998, 72:6742-6751.
10. Lee L.H. The use of monoclonal antibody probes for the detection of infectious bursal disease virus antigens. Avian Pathol. 1992, 21:87-96.
11. Lee L.H., Lu Y.S., Li N.J. Characterization of infections bursal disease virus isolated in Taiwan. J. Chin. Soc. Vet. Sci. 1988, 14:89-100.
12. Lee L.H., Yu S.L., Shieh H.K. Detection of infectious bursal disease virus infection using the polymerase chain reaction. J. Virol. Methods 1992, 40:243-253.
13. Lui V.W., He Y., Falo L., Huang L. Systemic administration of naked DNA encoding interleukin 12 for the treatment of human papillomavirus DNA-positive tumor. Hum. Gene Ther. 2002, 13:177-185.
14. Ma X., Trinchieri G. Regulation of interleukin-12 production in antigen-presenting cells. Adv. Immunol. 2001, 79:55-92.
15. Medrano G., Dolan M.C., Stephens N.T., McMickle A., Erf G., Radin D., Cramer C.L. Efficient plant-based production of chicken interleukin-12 yields a strong immunostimulatory cytokine. J. Interferon Cytokine Res. 2010, 30:143-154.
16. Metzger D.W. IL-12 as an adjuvant for the enhancement of protective humoral immunity. Expert Rev. Vaccines 2009, 8:515-518.
17. Muskett J.C., Hopkins I.G., Edwards K.R., Thornton D.H. Comparison of two infectious bursal disease vaccine strains: efficacy and potential hazards in susceptible and maternally immune birds. Vet. Rec. 1979, 104:332-334.
18. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
19. Su B.S., Yin H.S., Shien J.H., Chiu H.H., Lee L.H. Production of biologically active chicken interleukin (IL) -12 and IL-18 synthesized by the recombinant fowlpox virus. Process Biochem. 2010, 45:1057-1064.
20. Takehara K., Kikuma R., Ishikawa S., Kamikawa M., Nagata T., Yokomizo Y., Nakamura M. Production and in vivo testing of a recombinant bovine IL-12 as an adjuvant for Salmonella typhimurium vaccination in calves. Vet. Immunol. Immunopathol. 2002, 86:23-30.
21. Thomas J.D., Morris K.R., Godfrey D.I., Lowenthal J.W., Bean A.G. Expression, purification and characterisation of recombinant Escherichia coli derived chicken interleukin-12. Vet. Immunol. Immunopathol. 2008, 126:403-406.
22. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
23. Tsai H.J., Tsai M.C., Tseng C.H. Detection of genetic variation in the VP2 gene of vaccine and field strains of infectious bursal disease viruses. Taiwan Vet. J. 2002, 28:242-251.
24. Wang M.Y., Kuo Y.Y., Lee M.S., Doong S.R., Ho J.Y., Lee L.H. Self-assembly of the infectious bursal disease virus capsid protein, rVP2, expressed in insect cells and purification of immunogenic chimeric rVP2H particles by immobilized metal-ion affinity chromatography. Biotechnol. Bioeng. 2000, 67:104-111.
25. Xu X., Sun Y.L., Hoey T. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain. Science 1996, 273:794-797.